Abbott announced today that it received approval from the FDA for the launch of its Liberta RC DBS system. Liberta RC DBS (rechargeable deep brain stimulation) features remote programming for treating people with movement disorders. Abbott says it requires the fewest recharges of any FDA-approved DBS system, needing just 10 recharge sessions a year for […]
Implants
Motif Neurotech raises $18.75M Series A for miniature brain pacemaker
Motif Neurotech announced today that it brought in a Series A financing round worth proceeds of $18.75 million. Arboretum Ventures led the financing with new investors KdT Ventures, Satori Neuro, Dolby Family Ventures and re.Mind Capital participating. Existing investors Divergent Capital, TMC Innovation, PsyMed Ventures, Empath Ventures and Capital Factory contributed as well. The company […]
Boston Scientific has positive spinal cord stimulation data
Boston Scientific announced positive one-year results from a trial evaluating its spinal cord stimulation (SCS) technology. The SOLIS randomized control trial demonstrated sustained pain relief with the WaveWriter Alpha SCS system for treating non-surgical back pain (NSBP). Boston Scientific presented data at the 2024 North American Neuromodulation Society (NANS) meeting in Las Vegas. Dr. James […]
Axogen has positive nerve implant data
Axogen (Nasdaq:AXGN) announced positive topline results from a clinical study evaluating its Axoguard Nerve Cap. The REPOSE study compares standard-of-care neurectomy of symptomatic neuroma to neurectomy and protection of the terminated nerve end with the Axoguard Nerve Cap. Axoguard Nerve Cap is a proprietary surgical implant. Derived from porcine submucosal extracellular matrix remodeled during healing, […]
Accelus picks up $20M to support expandable spine implant tech
Accelus announced that it received a significant financial investment through a $20 million debt facility from Symbiotic Capital. Palm Beach Gardens, Florida-based Accelus says the strategic funding represents a critical milestone in the company’s journey. It aims to establish itself as the global market leader in expandable spinal implant solutions. Adding the capital strengthens its […]
Medtronic has first U.S. implants of its recently approved DBS tech
Doctors have completed the first U.S. implants of the Medtronic Percept RC neurostimulator for deep brain stimulation (DBS). In a LinkedIn post, Medtronic VP and GM for Brain Modulation, Amaza Reitmeier, confirmed the milestone. Percept RC received FDA approval earlier this month, with company officials calling it a “game-changing” device. “I’m delighted to announce the […]
Nevro earns coverage win for spinal cord stimulation
Nevro (NYSE:NVRO) announced that Carelon Healthcare plans to expand its spinal cord stimulation (SCS) coverage. Carelon plans to publish a new interventional pain management policy expanding SCS coverage for painful diabetic neuropathy (PDN). The policy, set to go into effect on April 14, increases PDN patient coverage by nearly 43 million additional lives. Payers that […]
Medtronic has positive spinal cord stimulation data
Medtronic today announced data from two clinical trials supporting its spinal cord stimulation (SCS) technologies. The medtech giant shared data at the North American Neuromodulation Society (NANS) annual meeting in Las Vegas. Results demonstrated the benefits of SCS in patients with chronic low back pain (CLBP) and leg pain. The company also plans to highlight […]
Onward begins neurostim study to address post-spinal cord injury hemodynamic instability
Onward Medical announced today that it began the HemON NL clinical feasibility study to evaluate its ARC-IM neurostimulation therapy. Onward said that, in late 2023, a study participant received the investigational ARC-IM neurostimulator and lead implant. This study aims to assess the safety and effectiveness of the therapy to address hemodynamic instability after spinal cord […]
FDA approves expanded MRI labeling for Abbott Proclaim neurostim
Abbott announced today that the FDA approved expanded MRI labeling for its Proclaim DRG neurostimulation system. Proclaim DRG provides targeted relief for people with complex regional pain syndrome (CRPS) types I and II of the lower limbs. It stimulates the dorsal root ganglion (DRG) clusters of nerve cells found along the spine. Abbott says four […]
FDA warns on defective packaging with Exactech shoulder system
The FDA issued a warning related to possible health risks associated with the Exactech Equinoxe shoulder system joint replacement devices. Equinoxe devices replace painful shoulder joints due to osteoarthritis, osteonecrosis, rheumatoid arthritis and/or loss of normal structure and function. The devices also improve previously failed shoulder joint replacement devices with adequate bone and soft tissue […]